KALARIS THERAPEUTICS INC (KLRS) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:KLRS • US4829291065

8.88 USD
-0.32 (-3.48%)
At close: Jan 30, 2026
9.5 USD
+0.62 (+6.98%)
After Hours: 1/30/2026, 8:01:20 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
KLRS revenue by date.KLRS revenue by date.
1.14M170K
-85.09%

-100.00%
390.15K16.32M
-100.00%
6.656M29.772M
347.30%
85.803M
188.20%
189.55M
120.91%
396.61M
109.24%
EBITDA
YoY % growth
KLRS ebitda by date.KLRS ebitda by date.
-3.6M-26.68M
-641.11%
-73.44M
-167.02%
-166.26M
-138.11%
-176.978M
-0.50%
-192.667M
-5.94%
-70.115M
61.18%
-55.995M
20.14%
-62.525M
-11.66%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
KLRS ebit by date.KLRS ebit by date.
-3.6M-26.7M
-641.67%
-75.066M
-167.08%
-169.409M
-138.14%
-184.517M
-0.81%
-189.785M
-5.72%
-65.032M
69.61%
-49.782M
9.49%
-60.918M
-22.37%
-66.657M
-9.42%
-108.564M
-62.87%
-120.667M
-11.15%
-141.723M
-17.45%
-165.183M
-16.55%
-103.032M
37.63%
35.744M
134.69%
Operating Margin
KLRS operating margin by date.KLRS operating margin by date.
-315.79%-15,705.88%N/A-43,421.52%N/AN/AN/AN/AN/A-408.44%N/A-1,812.90%-476.03%-192.51%-54.36%9.01%
EPS
YoY % growth
KLRS eps by date.KLRS eps by date.
N/AN/A-105.96-61.86
40.53%
-52.71
17.88%
-40.96
25.78%
-0.51
98.68%
-3.77
-644.22%
-2.53
32.88%
-1.63
35.41%
-2.54
-55.70%
-1.89
25.55%
-2.07
-9.11%
-2.10
-1.81%
-1.06
49.44%
0.60
156.55%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.54
-624.81%
-0.64
74.47%
-0.65
-6.93%
-0.64
-0.53%
-0.60
-10.58%
-0.46
28.34%
-0.75
-14.78%
-0.90
-39.99%
-1.05
-75.75%
-1.20
-161.28%
-1.36
-81.06%
-1.50
-67.04%
Revenue
Q2Q % growth
N/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-13.706M
29.80%
-14.154M
-36.70%
-14.7M
-19.94%
-15.282M
-19.94%
-15.901M
-16.01%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.64
-560.47%
-0.670.033.88%
Q2 2025
Q2Q % growth
-0.61
46.96%
-0.53-0.08-15.01%
Q1 2025
Q2Q % growth
-2.52
57.86%
-0.79-1.73-218.79%
Q4 2024
Q2Q % growth

99.10%
-0.07%
Q3 2024
Q2Q % growth

98.92%
-0.10%
Q2 2024
Q2Q % growth
-1.15
89.58%
-2.461.3153.31%
Q1 2024
Q2Q % growth
-5.98
40.91%
-3.68-2.30-62.70%
Q4 2023
Q2Q % growth
-8.28
2.70%
-10.041.7617.54%
Q3 2023
Q2Q % growth
-8.97
22.00%
-9.760.798.09%
Q2 2023
Q2Q % growth
-11.04
30.43%
-10.56-0.48-4.58%
Q1 2023
Q2Q % growth
-10.12
36.23%
-10.910.797.23%
Q4 2022
Q2Q % growth
-8.51
59.78%
-12.754.2433.24%
Q3 2022
Q2Q % growth
-11.50
30.56%
-12.360.866.93%
Q2 2022
Q2Q % growth
-15.87
-15.00%
-17.131.267.33%
Q1 2022
Q2Q % growth
-15.87
-38.00%
-18.692.8215.09%
Q4 2021
Q2Q % growth
-21.16
-170.59%
-19.08-2.08-10.90%
Q3 2021
Q2Q % growth
-16.56
-24.14%
-12.90-3.66-28.34%
Q2 2021
Q2Q % growth
-13.80 -11.50-2.30-20.05%
Q1 2021
Q2Q % growth
-11.50 -9.44-2.06-21.79%
Q4 2020
Q2Q % growth
-7.82 -9.852.0320.63%
Q3 2020
Q2Q % growth
-13.34 -7.04-6.30-89.54%
KLRS Yearly EPS VS EstimatesKLRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60 -80 -100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
KLRS Yearly Revenue VS EstimatesKLRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2021 2027 2029 2030 2031 2032 2033 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 12.87% 3.43% -1.27%
RevenueN/A N/A N/A N/A